Benzodiazepine use among patients with schizophrenia in Taiwan: A nationwide population-based survey

Psychiatric Services

Volumn 62, Issue 8, 2011, Pages 908-914

  Wu, Chi Shin ^a   Lin, Yu Ju ^a   Liu, Shi Kai ^a  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; COMORBIDITY; DEMOGRAPHY; DISEASE DURATION; DRUG USE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; POLYPHARMACY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; SCHIZOPHRENIA; SENESCENCE; TAIWAN; TREATMENT DURATION;

EID: 79961100326     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.62.8.pss6208_0908     Document Type: Article

References (29)

1. The Global Burden of Disease: 2004 Update. Geneva, World Health Organization, 2004. Available at www.who.int/healthinfo/global-burden-disease/ 2004-report-update/en/index.html
2. Haw C, Stubbs J: Benzodiazepines - a necessary evil? A survey of prescribing at a specialist UK psychiatric hospital. Journal of Psychopharmacology 21:645-649, 2007 (Pubitemid 47472729)
3. Wolkowitz OM, Pickar D: Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. American Journal of Psychiatry 148:714-726, 1991
4. Volz A, Khorsand V, Gillies D, et al: Benzodiazepines for schizophrenia. Cochrane Database of Systematic Reviews 1:CD006391, 2007. DOI 10.1002/14651858.CD006391
5. Brunette MF, Noordsy DL, Xie H, et al: Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiatric Services 54:1395-1401, 2003 (Pubitemid 37220041)
6. Dixon L: Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophrenia Research 35(suppl):S93-S100, 1999
7. Green MF: Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. Journal of Clinical Psychiatry 67:(suppl 9):3-8, 2006
8. Liu SK, Chiu CH, Chang CJ, et al: Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers. American Journal of Psychiatry 159:975-982, 2002 (Pubitemid 34586943)
9. Barker MJ, Greenwood KM, Jackson M, et al: Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 18:37-48, 2004 (Pubitemid 38197758)
10. Wu CS, Wang SC, Chang IS, et al: The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data. American Journal of Geriatric Psychiatry 17:614-620, 2009
11. Chakos MH, Glick ID, Miller AL, et al: Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial. Psychiatric Services 57:1094-1101, 2006 (Pubitemid 44204901)
12. Novick D, Bousono M, Suarez D, et al: Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29:972-982, 2005 (Pubitemid 41080120)
13. Clark RE, Xie H, Brunette MF: Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. Journal of Clinical Psychiatry 65:151-155, 2004
14. Karagianis J, Novick D, Pecenak J, et al: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients. International Journal of Clinical Practice 63:1578-1588, 2009
15. Verma SK, Subramaniam M, Chong SA, et al: Substance abuse in schizophrenia: a Singapore perspective. Social Psychiatry and Psychiatric Epidemiology 37:326-328, 2002 (Pubitemid 36076012)
16. Lin HC, Hsiao FH, Pfeiffer S, et al: An increased risk of stroke among young schizophrenia patients. Schizophrenia Research 101:234-241, 2008
17. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 40:373-383, 1987 (Pubitemid 17055592)
18. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology 45:613-619, 1992
19. Guidelines for ATC Classification and DDD Assignment. Oslo, Norway, World Health Organization, Collaborating Centre for Drug Statistic Methodology, 2009
20. Merlo J, Wessling A, Melander A: Comparison of dose standard units for drug utilisation studies. European Journal of Clinical Pharmacology 50:27-30, 1996 (Pubitemid 26141504)
21. Zandstra SM, Furer JW, van de Lisdonk EH, et al: Different study criteria affect the prevalence of benzodiazepine use. Social Psychiatry and Psychiatric Epidemiology 37:139-144, 2002 (Pubitemid 36097270)
22. Fang SY, Chen CY, Chang IS, et al: Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study. Drug and Alcohol Dependence 104:140-146, 2009
23. Valenstein M, Taylor KK, Austin K, et al: Benzodiazepine use among depressed patients treated in mental health settings. American Journal of Psychiatry 161:654-661, 2004 (Pubitemid 38445509)
24. Neutel CI: The epidemiology of long-term benzodiazepine use. International Review of Psychiatry 17:189-197, 2005
25. Guidelines for Benzodiazepine Using in Sedation and Hypnosis. Taipei, Taiwan, Executive Yuan, Department of Health, Food and Drug Administration. Available at www.fda.gov.tw/files/people-laws/ guidelines%20for%20Benzodiazepine%20Using%20in%20Sedation%20and%20Hypnosis.pdf
26. Baldwin DS, Anderson IM, Nutt DJ, et al: Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 19:567-596, 2005 (Pubitemid 41578819)
27. Nakajima S, Uchida H, Suzuki T, et al: An open-label trial of discontinuing benzodiazepines in patients with chronic schizophrenia. Journal of Clinical Psychopharmacology 27:401-403, 2007 (Pubitemid 47075516)
28. Neutel CI: The epidemiology of long-term benzodiazepine use. International Review of Psychiatry 17:189-197, 2005
29. Lurie N, Popkin M, Dysken M, et al: Accuracy of diagnoses of schizophrenia in Medicaid claims. Hospital and Community Psychiatry 43:69-71, 1992